Pima Heart

Tucson, Arizona 85745

2 studies enrolling now · 9 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), CHF, Cardiovascular Disease, Chronic Heart Disease, Congestive Heart Failure, Diabetes Mellitus, Type 2, Elevated Lp(a), Heart Failure, Heart Failure With Preserved Ejection Fraction, Homozygous Familial Hypercholesterolemia, NYHA Class III Heart Failure, NYHA Class IV Heart Failure

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• LOWER: Lomitapide Observational Worldwide Evaluation Registry — Completed
• A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) — Stopped early
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System — Stopped early
• Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C — Completed
• Cardiovascular Inflammation Reduction Trial — Completed